Bengal Infertility & Reproductive Therapy Hospital Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 24-10-2024
- Paid Up Capital ₹ 3.35 M
as on 24-10-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 19.90%
(FY 2023)
- Profit 83.00%
(FY 2023)
- Ebitda 72.07%
(FY 2023)
- Net Worth 31.74%
(FY 2023)
- Total Assets 12.50%
(FY 2023)
About Bengal Infertility & Reproductive Therapy Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 3.35 M, as per Ministry of Corporate Affairs (MCA) records.
Aparna Khastgir and Gautam Khastgir serve as directors at the Company.
- CIN/LLPIN
U85199WB2004PTC098093
- Company No.
098093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bengal Infertility & Reproductive Therapy Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aparna Khastgir  | Director | 15-Mar-2004 | Current |
| Gautam Khastgir | Director | 15-Mar-2004 | Current |
Financial Performance of Bengal Infertility & Reproductive Therapy Hospital.
Bengal Infertility & Reproductive Therapy Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.9% increase. The company also saw a substantial improvement in profitability, with a 83% increase in profit. The company's net worth Soared by an impressive increase of 31.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bengal Infertility & Reproductive Therapy Hospital?
In 2023, Bengal Infertility & Reproductive Therapy Hospital had a promoter holding of 98.51% and a public holding of 1.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agk Professional Services Private LimitedActive 6 years 6 monthsAparna Khastgir and Gautam Khastgir are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bengal Infertility & Reproductive Therapy Hospital?
Bengal Infertility & Reproductive Therapy Hospital has a workforce of 69 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bengal Infertility & Reproductive Therapy Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengal Infertility & Reproductive Therapy Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
